Cecil T. Holbert

Family Medicine

3 Healthcare Dr
Philippi, WV 26416

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.

Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.

Journal: Clinical immunology (Orlando, Fla.)

Published: September 27, 2016

Showing 1-1 of 1

Last Updated: 09/26/2026